Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hong Kong debates reproductive technology bill:

This article was originally published in Clinica

Executive Summary

Hong Kong's Legislative Council debated a reproductive technology bill for the first time last week, which aims to prevent embryo gender selection on non-medical grounds. If passed, the Human Reproductive Technology Bill would also impose stringent controls on artificial fertilisation, reports the South China Morning Post. The bill provides for the setting up of a statutory body to oversee establishments engaged in embryo research.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT082004

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel